These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 5068883)
1. [Clofibrate and coronary disease]. Nikkilä E Duodecim; 1972; 88(10):684-7. PubMed ID: 5068883 [No Abstract] [Full Text] [Related]
2. [Effect of clofibrate on glucide tolerance in patients with ischemic heart disease and hyperlipoproteinemia]. Bornemisza P; Csögör I Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1978; 30(6):543-6. PubMed ID: 34860 [No Abstract] [Full Text] [Related]
3. [Results of a 5-year study of the action of clofibrate in the treatment of ischemic cardiopathy]. Dewar HA Minerva Med; 1971 Sep; 62(72):3456-7. PubMed ID: 5097216 [No Abstract] [Full Text] [Related]
4. Clofibrate and niacin in coronary heart disease. JAMA; 1975 Jan; 231(4):360-81. PubMed ID: 1088963 [No Abstract] [Full Text] [Related]
5. The influence of Clofibrat on plasma lipid levels. Szostak WB; Cybulska B; Ruzyllo E Mater Med Pol; 1971; 3(4):12-4. PubMed ID: 5162168 [No Abstract] [Full Text] [Related]
6. Clofibrate in the treatment and prevention of ischaemic heart disease: recent trials. Drug Ther Bull; 1972 Aug; 10(17):65-6. PubMed ID: 4570864 [No Abstract] [Full Text] [Related]
7. Cholesterol, clofibrate and ischaemic heart disease. Facts and emotions around. Fejfar Z Cor Vasa; 1979; 21(6):377-9. PubMed ID: 397875 [No Abstract] [Full Text] [Related]
12. Clofibrate in coronary heart disease. Effect on morbidity and mortality. Krasno LR; Kidera GJ JAMA; 1972 Feb; 219(7):845-51. PubMed ID: 5066667 [No Abstract] [Full Text] [Related]
13. The influence of clofibrate on glucose tolerance in patients with coronary heart disease. Ruzyllo E; Szostak WB; Cybulska B Pol Arch Med Wewn; 1972 Feb; 49(2):121-3. PubMed ID: 4670209 [No Abstract] [Full Text] [Related]
14. [The clofibrate-dipyridamole combination in the prevention and therapy of arteriosclerotic vascular disease and its complications]. Cucinotta D; Ferretti PG; Daccò L; Mazzera F G Clin Med; 1977; 58(11-12):475-86. PubMed ID: 608558 [No Abstract] [Full Text] [Related]
15. Influence of treatment adherence in the coronary drug project. N Engl J Med; 1981 Mar; 304(10):612-3. PubMed ID: 7005674 [No Abstract] [Full Text] [Related]
16. Five-year trial of clofibrate in ischaemic heart disease. Dewar HA Br Heart J; 1971 Jan; 33(1):145. PubMed ID: 5541898 [No Abstract] [Full Text] [Related]
17. [Therapeutic results with combination of pyridinolcarbamate and clofibrate in atherosclerotic patients]. Valiensi M; Riboli E; Lombardi M Minerva Cardioangiol; 1976 Feb; 24(2):148-54. PubMed ID: 1256654 [No Abstract] [Full Text] [Related]
18. [Effects of clofibrate, Isopharm, on fat tolerance in atherosclerotic patients]. Passowicz L Pol Tyg Lek; 1972 Jul; 27(30):1163-6. PubMed ID: 5073024 [No Abstract] [Full Text] [Related]
19. [Treatment of chronic ischemic cardiopathy with a combination of pyridinolcarbamate and clofibrate]. Guerrera G; Melina D Clin Ter; 1980 Mar; 92(5):533-47. PubMed ID: 7449327 [No Abstract] [Full Text] [Related]